82
Nasdaq Stockholm has approved the company’s application subject to customary conditions. Bonesupport said it wants to broaden ist shareholder base through issuance of up to 18,518,519 new shares to institutional investors and the general public, worth SEK500m (€51.2m). Furthermore, the company issued an over-allotment option of up to 2,777,778 new shares, corresponding to additional SEK75m (€7.7m) or a maximum of 15% of the total number of shares in the offering. The final price, set to be established by 21 June, will be determined in a book-building procedure and is expected to be set within the range of SEK27-31 per share (€2.76-€3.17),…